Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
XTNT Stock Summary
Top 10 Correlated ETFs
XTNT
In the News
XTNT Financial details
Company Rating
Sell
Market Cap
109.02M
Income
660K
Revenue
91.3M
Book val./share
0.39
Cash/share
0.05
Dividend
-
Dividend %
-
Employees
207
Optionable
No
Shortable
Yes
Earnings
02 May 2024
P/E
55.83
Forward P/E
-
PEG
-5.6
P/S
1.99
P/B
2.81
P/C
16.6
P/FCF
-12.57
Quick Ratio
1.27
Current Ratio
2.92
Debt / Equity
0.44
LT Debt / Equity
-
-
-
EPS (TTM)
-0
EPS next Y
-
EPS next Q
-
EPS this Y
-106.1%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
7.14%
Revenue Q/Q
12.35%
EPS Q/Q
-145.97%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
78.39%
Inst Trans
1.04%
ROA
3%
ROE
7%
ROC
-0.12%
Gross Margin
59%
Oper. Margin
-10%
Profit Margin
4%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.58-1.45
52W High
-
52W Low
-
RSI
38
Rel Volume
0.78
Avg Volume
149.77K
Volume
116.62K
Perf Week
-5.68%
Perf Month
-29.66%
Perf Quarter
-23.85%
Perf Half Y
-24.55%
-
-
-
-
Beta
0.22
-
-
Volatility
0.03%, 0.12%
Prev Close
-0.86%
Price
0.83
Change
1.59%
XTNT Financial Performance
Quarterly Fundamentals Overview
Last date of statement is 2023-12-31 for Q4
Metric | History | 2022-12-31 | 2023-03-31 | 2023-06-30 | 2023-09-30 | 2023-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 0.14 | 0.16 | 0.19 | 0.2 | 0.22 | |
Net income per share | -0.02 | -0.02 | -0.02 | 0.07 | -0.03 | |
Operating cash flow per share | -0.02 | -0.02 | -0.02 | -0.03 | -0.01 | |
Free cash flow per share | -0.03 | -0.02 | -0.03 | -0.03 | -0.01 | |
Cash per share | 0.19 | 0.05 | 0.04 | 0.07 | 0.05 | |
Book value per share | 0.32 | 0.3 | 0.28 | 0.43 | 0.39 | |
Tangible book value per share | 0.28 | 0.13 | 0.12 | 0.29 | 0.26 | |
Share holders equity per share | 0.32 | 0.3 | 0.28 | 0.43 | 0.39 | |
Interest debt per share | 0.16 | 0.2 | 0.22 | 0.17 | 0.18 | |
Market cap | 71.5M | 69.42M | 101.26M | 140.95M | 146.93M | |
Enterprise value | 68.28M | 85.6M | 120.69M | 155.32M | 164.56M | |
P/E ratio | -8.09 | -8.35 | -11.56 | 3.82 | -8.54 | |
Price to sales ratio | 4.68 | 3.87 | 5.01 | 5.63 | 5.23 | |
POCF ratio | -31.25 | -30.92 | -40.17 | -36.76 | -160.58 | |
PFCF ratio | -26.18 | -25.7 | -34.5 | -34.74 | -114.97 | |
P/B Ratio | 2.09 | 2.12 | 3.27 | 2.58 | 2.86 | |
PTB ratio | 2.09 | 2.12 | 3.27 | 2.58 | 2.86 | |
EV to sales | 4.47 | 4.77 | 5.97 | 6.21 | 5.85 | |
Enterprise value over EBITDA | -40.33 | -84 | -205.25 | -45.88 | -59 | |
EV to operating cash flow | -29.84 | -38.13 | -47.87 | -40.51 | -179.85 | |
EV to free cash flow | -25 | -31.69 | -41.12 | -38.28 | -128.77 | |
Earnings yield | -0.03 | -0.03 | -0.02 | 0.07 | -0.03 | |
Free cash flow yield | -0.04 | -0.04 | -0.03 | -0.03 | -0.01 | |
Debt to equity | 0.5 | 0.66 | 0.76 | 0.42 | 0.44 | |
Debt to assets | 0.28 | 0.34 | 0.36 | 0.25 | 0.24 | |
Net debt to EBITDA | 1.91 | -15.88 | -33.03 | -4.24 | -6.32 | |
Current ratio | 3.24 | 2.12 | 2.33 | 2.92 | 2.82 | |
Interest coverage | -3.48 | -2.74 | -1.77 | 4.45 | -4.65 | |
Income quality | 1.04 | 1.08 | 1.15 | -0.42 | 0.21 | |
Dividend Yield | 0 | 0 | 0 | 0 | 0 | |
Payout ratio | 0 | 0 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.26 | 0.27 | 0.24 | 0.29 | 0.32 | |
Research and developement to revenue | 0.02 | 0.01 | 0.01 | 0.02 | 0.02 | |
Intangibles to total assets | 0.06 | 0.29 | 0.27 | 0.18 | 0.19 | |
Capex to operating cash flow | 0.19 | 0.2 | 0.16 | 0.06 | 0.4 | |
Capex to revenue | -0.03 | -0.03 | -0.02 | -0.01 | -0.01 | |
Capex to depreciation | -1.38 | -0.97 | -0.52 | -0.25 | -0.36 | |
Stock based compensation to revenue | 0.04 | 0.03 | 0.02 | 0.03 | 0.03 | |
Graham number | 0.38 | 0.36 | 0.36 | 0.83 | 0.54 | |
ROIC | -0.03 | -0.03 | -0.03 | -0.03 | -0.06 | |
Return on tangible assets | -0.04 | -0.05 | -0.05 | 0.12 | -0.06 | |
Graham Net | 0.1 | -0.06 | -0.09 | 0.02 | -0.01 | |
Working capital | 34.1M | 19.31M | 22.58M | 42.19M | 41.88M | |
Tangible asset value | 30.62M | 14.26M | 13.53M | 37.68M | 33.96M | |
Net current asset value | 23.26M | 5.98M | 5.31M | 26.79M | 23.61M | |
Invested capital | 0.5 | 0.66 | 0.76 | 0.42 | 0.44 | |
Average receivables | 10.35M | 11.38M | 12.82M | 16.45M | 19.94M | |
Average payables | 3.63M | 3.46M | 3.93M | 4.9M | 6.21M | |
Average inventory | 17.14M | 17.9M | 19.44M | 27.35M | 35.61M | |
Days sales outstanding | 63.97 | 59.7 | 61.14 | 68.89 | 66.38 | |
Days payables outstanding | 45.1 | 41.57 | 51.46 | 49.79 | 57.87 | |
Days of inventory on hand | 223.38 | 225.05 | 235.79 | 319.06 | 302.58 | |
Receivables turnover | 1.41 | 1.51 | 1.47 | 1.31 | 1.36 | |
Payables turnover | 2 | 2.17 | 1.75 | 1.81 | 1.56 | |
Inventory turnover | 0.4 | 0.4 | 0.38 | 0.28 | 0.3 | |
ROE | -0.06 | -0.06 | -0.07 | 0.17 | -0.08 | |
Capex per share | 0 | 0 | 0 | 0 | 0 |
XTNT Frequently Asked Questions
What is Xtant Medical Holdings, Inc. stock symbol ?
Xtant Medical Holdings, Inc. is a US stock , located in Belgrade of Mt and trading under the symbol XTNT
What is Xtant Medical Holdings, Inc. stock quote today ?
Xtant Medical Holdings, Inc. stock price is $0.83 today.
Is Xtant Medical Holdings, Inc. stock public?
Yes, Xtant Medical Holdings, Inc. is a publicly traded company.